SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-331251
Filing Date
2017-11-02
Accepted
2017-11-02 17:11:00
Documents
72
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d399214d10q.htm 10-Q 597309
2 EX-31.1 d399214dex311.htm EX-31.1 8385
3 EX-31.2 d399214dex312.htm EX-31.2 8375
4 EX-32.1 d399214dex321.htm EX-32.1 4095
  Complete submission text file 0001193125-17-331251.txt   4215501

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cara-20170930.xml EX-101.INS 847280
6 XBRL TAXONOMY EXTENSION SCHEMA cara-20170930.xsd EX-101.SCH 45493
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cara-20170930_cal.xml EX-101.CAL 64436
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cara-20170930_def.xml EX-101.DEF 199300
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cara-20170930_lab.xml EX-101.LAB 387606
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cara-20170930_pre.xml EX-101.PRE 313231
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36279 | Film No.: 171173445
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences